Allspring Global Investments
OCDX

Allspring Global Investments’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Allspring Global Investments’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-25,760
Closed -$480K – 3073
2022
Q1 		$480K Sell
25,760
-58,427
-69% -$1.05M ﹤0.01% 2241
2021
Q4 		$1.8M Buy
+84,187
New +$1.66M ﹤0.01% 1597

Other funds holding OCDX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Allspring Global Investments's OCDX Position: Q2 2022 in Review

Allspring Global Investments sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q2 2022, closing a stake of 25,760 shares — an estimated $480K sold.

Allspring Global Investments first reported a position in OCDX in Q4 2021 and held it in 2 quarters. The position peaked at $1.8M in Q4 2021. 1 fund tracked by Wall St. Rank holds OCDX as of Q2 2022.

  • Allspring Global Investments reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q2 2022 after selling out during the quarter.
  • Allspring Global Investments sold 25,760 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q2 2022, an estimated $480K.
  • Allspring Global Investments first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q4 2021 and held it in 2 quarters.
  • Allspring Global Investments's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $1.8M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q2 2022.

Based on Allspring Global Investments's 13F filing for Q2 2022, filed 25 Jul 2022.